Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells

被引:0
|
作者
Xi-Ping Tang [1 ]
Guo-Du Tang [1 ]
Chun-Yun Fang [1 ]
Zhi-Hai Liang [1 ]
Lu-Yi Zhang [1 ]
机构
[1] Department of Gastroenterology,First Affiliated Hospital,Guangxi Medical University
基金
中国国家自然科学基金;
关键词
Ginsenoside Rh2; Human pancreatic cancer Bxpc-3 cell; Proliferation; Apoptosis; Migration;
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
100214 ;
摘要
AIM:To investigate the effects of ginsenoside Rh2 on the human pancreatic cancer cell line Bxpc-3.METHODS:The human pancreatic cancer cell line Bxpc-3 was cultured in vitro and treated with or without ginsenoside Rh2.Growth rates for Bxpc-3 cells were assessed by methyl thiazolyl tetrazolium(MTT) and colony formation assays.Cell cycle changes were analyzed by flow cytometry.Apoptosis was measured by flow cytometry and Hoechst 33258 fluorescence staining.A scratch assay and a Matrigel invasion assay were used to detect cell migration and invasion.Expression of Bax,Bcl-2,survivin,cyclin D1,matrix metalloproteinase(MMP)-2,MMP-9,cleaved caspase-3,caspase-8,and caspase-9 mRNA were determined by reverse transcriptase-polymerase chain reaction(RT-PCR).Bax,Bcl-2,survivin,cyclin D1,cleaved caspase-3,caspase-8 and caspase-9 protein levels were examined by western blotting.Expression of MMP-2 and MMP-9 proteins in culture supernatants were determined by enzymelinked immunosorbent assay(ELISA).RESULTS:Rh2 significantly inhibited Bxpc-3 cell proliferation in a dose-and time-dependent manner,as evaluated by the MTT(P < 0.05) and colony formation assays(P < 0.05).Compared to the control group,Rh2 significantly increased the percentage of Bxpc-3 cells in the G 0 /G 1 phase from 43.32% ± 2.17% to 71.32% ± 1.16%,which was accompanied by a decrease in S phase(from 50.86% ± 1.29% to 28.48% ± 1.18%) and G 2 /M phase(from 5.81% ± 1.19% to 0.20% ± 0.05%) in a dose-dependent manner(P < 0.05),suggesting that Rh2 arrested cell cycle progression at the G 0 /G 1 phase,as measured by flow cytometry.Compared to the control group,cells treated with Rh2 showed significantly higher apoptosis ratios in a dosedependent manner(percentage of early apoptotic cells:from 5.29% ± 2.28% to 38.90% ± 3.42%(F = 56.20,P < 0.05);percentage of late apoptotic cells:from 4.58% ± 1.42% to 36.32% ± 2.73%(F = 86.70,P < 0.05).Rh2 inhibited Bxpc-3 cell migration and invasion,as detected by scratch wound healing assay and Matrigel invasion assay [percentages of scratch wound healing for 12 h,24 h and 48 h(control vs experimental group):37.3% ± 4.8%vs 18.30% ± 1.65%,58.7% ± 3.5% vs 38.00% ± 4.09% and 93.83% ± 4.65% vs 65.50% ± 4.09%,respectively;t = 6.489,t = 6.656 and t = 7.926,respectively,P < 0.05;the number of cells invading at various concentrations(0 μmol/L,35 μmol/L,45 μmol/L and 55 μmol/L):81.10 ± 9.55,46.40 ± 6.95,24.70 ± 6.88 and 8.70 ± 3.34,respectively(F = 502.713,P < 0.05)].RT-PCR,western blotting or ELISA showed that mRNA and protein expression of Bax,cleaved caspase-3 and caspase-9 were upregulated(P < 0.05),while mRNA and protein expression of Bcl-2,survivin,cyclin D1,MMP-2 and MMP-9 were downregulated(P < 0.05).CONCLUSION:Ginsenoside Rh2 inhibits proliferation,migration and invasion and induces apoptosis of the human pancreatic cancer cell line Bxpc-3.
引用
收藏
页码:1582 / 1592
页数:11
相关论文
共 50 条
  • [41] Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells
    Liu, Ze-Hong
    Li, Jing
    Xia, Jing
    Jiang, Rong
    Zuo, Guo-Wei
    Li, Xiao-Peng
    Chen, Yi
    Xiong, Wei
    Chen, Di-Long
    CHEMICO-BIOLOGICAL INTERACTIONS, 2015, 242 : 227 - 234
  • [42] Study on the molecular mechanism of ginsenoside Rh2 anticancer activity
    Jin, Ying-Hua
    Wang, Yushi
    Lin, Yingjia
    Li, He
    Li, Yang
    CANCER SCIENCE, 2018, 109 : 1000 - 1000
  • [43] Pharmacokinetics and metabolic pathways of ginsenoside Rh2 in rat and dog
    Duan, Xiaotao
    Chen, Xiaoyan
    Li, Minghui
    Song, Bo
    Zhong, Dafang
    DRUG METABOLISM REVIEWS, 2006, 38 : 109 - 109
  • [44] Establishment of Measurement System of Ginsenoside Rh2 Glycosyltransferase Activity
    HE Yan-ping
    Medicinal Plant, 2010, (04) : 58 - 60
  • [45] Research Progress on the Antitumor Molecular Mechanism of Ginsenoside Rh2
    Yang, Lan
    Chen, Jenny Jie
    Teo, Brian Sheng-Xian
    Zhang, Jiong
    Jiang, Mingqiang
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2024, 52 (01): : 217 - 230
  • [46] Ginsenoside Rh2 reduces ischemic brain injury in rats
    Park, EK
    Choo, MK
    Oh, JK
    Ryu, JH
    Kim, DH
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (03) : 433 - 436
  • [47] Ginsenoside Rh2 Inhibited Proliferation by Inducing ROS Mediated ER Stress Dependent Apoptosis in Lung Cancer Cells
    Ge, Guanqun
    Yan, Yan
    Cai, Hui
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (12) : 2117 - 2124
  • [48] 1α,25-Dihydroxyvitamin D3 synergistically enhances anticancer effects of ginsenoside Rh2 in human prostate cancer cells
    Ben-Eltriki, Mohamed
    Deb, Subrata
    Guns, Emma S. Tomlinson
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2021, 209
  • [49] Activity of ginsenoside Rh2 on the growth of mice splenic lymphocytes investigated by microcalorimetry and factor analysis
    Yanling Zhao
    Jiabo Wang
    Limei Shan
    Ruisheng Li
    Dan Yan
    Xiaohe Xiao
    Journal of Thermal Analysis and Calorimetry, 2011, 105 : 1037 - 1041
  • [50] Ginsenoside Rh2 inhibits vascular endothelial growth factor-induced corneal neovascularization
    Zhang, Xiao-Pei
    Li, Ke-Ran
    Yu, Qing
    Yao, Mu-Di
    Ge, Hui-Min
    Li, Xiu-Miao
    Jiang, Qin
    Yao, Jin
    Cao, Cong
    FASEB JOURNAL, 2018, 32 (07): : 3782 - 3791